The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Happiness in Rheumatology

Happiness in Rheumatology

March 12, 2019 • By Richard Quinn

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Rheumatologists are the happiest medical specialists outside of work, according to a recent report. Approximately 65% of rheumatologists said they were happy, the Medscape Physician Lifestyle & Happiness Report 2019 reported. That’s up from 54% last year, when the specialty ranked fourth in the annual report.1,2

You Might Also Like
  • Life, Happiness, and the Pursuit of Rheumatology
  • What Rheumatologists Are Paid
  • The Pay Disparity: Rheumatologist Pay Is Up, but It’s Still a Lower-Paid Specialty
Also By This Author
  • Dr. Michael Weinblatt Discusses Current & Future RA Therapies

“It’s a significant finding because it’s repeated,” says Simon Helfgott, MD, an associate professor of medicine in the Division of Rheumatology, Immunology and Allergy at Harvard Medical School, Boston, and a past physician editor of The Rheumatologist. Dr. Helfgott has written about work–life balance issues in the field. “[This result] tells us that we have done something right in rheumatology in that we have been able to blend an interesting, intellectually stimulating profession and practice with the ability to help people,” he says.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Anne Bass, MD, past chair of the ACR’s Committee on Rheumatology Training and Workforce Issues and rheumatology fellowship program director for the Hospital for Special Surgery, New York, put it even more succinctly, “You don’t go into rheumatology to make a lot of money. You do it because you’re interested in it.”

To be fair, the average annual salary for rheumatologists climbed to $257,000 last year—up from $209,000 three years prior, according to a Medscape survey released last spring.3

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Advances in Patient Care
But Drs. Bass and Helfgott don’t see the field’s finances as a factor in the happiness ranking. Both point toward the field’s decades-long progression in treatment options. Years ago, rheumatologists had little in their toolbox to offer patients: aspirin, steroids and gold. Now, prescribing patients TNF inhibitors and other biologics is included in standard treatment plans.

“I’ll date myself, but when I was a fellow, we would kind of reserve methotrexate for the most severe cases of rheumatoid arthritis (RA), and it was almost like you didn’t want to use it too early because if it didn’t work, there wasn’t much else you could do for the patient,” Dr. Helfgott says. “And now we use methotrexate as the start of the line for your patient with RA and other diseases.”

“Looking at my own career and my own experience, it’s so much more satisfying to make people better,” Dr. Bass says. “That’s why we became doctors.”

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Bass says she’s even more hopeful scientific breakthroughs will continue to occur in the coming years and will further bolster rheumatologists’ options for treating diseases, such as scleroderma and system lupus erythematosus (SLE). “Having lots of choices, knowing that every year there will be new options available, and having much more of an optimistic view … is huge,” she says.

Dr. Helfgott warns that physicians’ happiness could wane if the non-medical complications of healthcare continue to be obstacles. As evidence of rheumatologists’ frustration, 68% of those surveyed said bureaucratic tasks, such as paperwork, have contributed the most to burnout.

Example: Dr. Helfgott says fighting with insurance companies and pharmacy benefit managers can be frustrating, especially when prescriptions for TNF inhibitors and other biologics require pre-approval. Compare rheumatologists with oncologists, Dr. Helfgott says. When it comes to cancer therapy, most insurance plans will approve the request, whereas rheumatologists face a greater struggle to gain approval for drugs to treat autoimmune disorders.

“A lot of this happiness will be predicated on … something out of our control,” Dr. Helfgott says. “These can be fleeting circumstances if we don’t work hard with the ACR to push back on some of the onerous tasks that wear people down. Even though we may be the happiest people, at some point, even a happy person may throw in the towel if they feel like all they do all day is fight for prior authorizations.”

Learn how you can help the ACR advocate for the interests of rheumatologists and our patients by visiting the ACR website.


Richard Quinn is a freelance writer in New Jersey.

References

  1. Martin KL.Medscape physician lifestyle and happiness report 2019. Medscape. 2019 Jan 9.
  2. Peckham C. Medscape physician lifestyle and happiness report 2018. Medscape. 2018 Jan 10.
  3. Kane L. Medscape physician compensation report 2018. Medscape. 2018 Apr 11.

Pages: 1 2 | Multi-Page

Filed Under: Professional Topics

You Might Also Like:
  • Life, Happiness, and the Pursuit of Rheumatology
  • What Rheumatologists Are Paid
  • The Pay Disparity: Rheumatologist Pay Is Up, but It’s Still a Lower-Paid Specialty
  • Rheumatologists’ Pay Increases for 3rd Year in a Row

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)